ENvue Medical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FEED research report →
Range $4.65 – $4.65
Price Chart
About the company
NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield.
- CEO
- Doron Robert Besser
- IPO
- 2025
- Employees
- 13
- HQ
- Tyler, TX, US
Get TickerSpark's AI analysis on FEED
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $797.96K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.41
- P/B
- 0.02
- EV/EBITDA
- -0.07
- Div Yield
- 0.00%
- Gross Margin
- -26.06%
- Op Margin
- -783.59%
- Net Margin
- -1088.94%
- ROE
- -60.47%
- ROIC
- -45.89%
Latest fiscal year · YoY change
- Revenue
- $2.55M-0.2%
- Gross Profit
- $153.00K-89.9%
- Op Income
- $-11,735,000
- Net Income
- $-18,185,000-390.8%
- EPS
- $-234.48+85.8%
- OCF Growth
- -272.5%
- FCF Growth
- -274.4%
- 52W High
- $5.98
- 52W Low
- $0.29
- 50D MA
- $4.00
- 200D MA
- $4.00
- Beta
- 1.56
- RSI (14)
- 20
- Avg Volume
- 0
No earnings-call transcripts are available for FEED yet.
- Free Float
- 87.3%
- Shares Outstanding
- 923.72K
- Float Shares
- 676.27K
of shares held by institutions
13 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Hrt Financial LP | 115.58K | ▲ 115.58K |
| Virtu Financial LLC | 95.30K | ▲ 95.30K |
| Jane Street Group, LLC | 37.63K | ▲ 37.63K |
| Geode Capital Management, LLC | 15.47K | ▼ 6.95K |
| Two Sigma Securities, LLC | 10.28K | ▲ 10.28K |
| Advisor Group Holdings, Inc. | 10.00K | 0 |
| Tower Research Capital LLC (Trc) | 4.78K | ▲ 1.96K |
| Global Retirement Partners, LLC | 1.60K | ▲ 1.60K |
| Vanguard Capital Management LLC | 189 | 0 |
| Vanguard Fiduciary Trust Co | 85 | 0 |
| Wells Fargo & Company/Mn | 45 | 0 |
| Sbi Securities Co., Ltd. | 15 | 0 |
Held by 4 ETFs
Biggest fund positions in FEED by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 15, 26 | Glibert Christian Michael | other | 0 |
| Dec 18, 25 | Fernandez-McGovern Nicole M. | other | 0 |
| Jan 14, 26 | Glibert Christian Michael | other | 0 |
| Jan 14, 26 | Glibert Christian Michael | buy | 240,000 |
| Jan 30, 26 | BANK OF AMERICA CORP /DE/ | other | 0 |
| Feb 2, 26 | BANK OF AMERICA CORP /DE/ | sell | 100 |
| Feb 2, 26 | BANK OF AMERICA CORP /DE/ | sell | 10 |
| Feb 2, 26 | BANK OF AMERICA CORP /DE/ | sell | 4 |
| Feb 2, 26 | BANK OF AMERICA CORP /DE/ | sell | 4 |
| Feb 2, 26 | BANK OF AMERICA CORP /DE/ | sell | 100 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our FEED coverage
Recent articles, reports, and earnings notes.
No research on FEED yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FEED report →Nanovibronix, Inc. (NASDAQ:FEED) Stock Short Interest Drops 81.6%
defenseworld.net · Sep 25
ENvue Medical Provides Nasdaq Listing Update
globenewswire.com · Sep 15
ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders
globenewswire.com · Sep 9
ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange
globenewswire.com · Sep 2
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
globenewswire.com · Aug 18
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions
globenewswire.com · Aug 12
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
globenewswire.com · Aug 4
ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center
globenewswire.com · Jul 23
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.